Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis

NCT01119339 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: LAS 41004
DRUG: LAS 41004
DRUG: LAS 41004
DRUG: LAS 41004
DRUG: LAS 41004
DRUG: LAS 41004 dosage 6
DRUG: Placebo
DRUG: Reference

Sponsor

Almirall, S.A.